Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

BACKGROUND: FibroTest (FT) is a validated biomarker of fibrosis. To assess the applicability rate and to reduce the risk of false positives/negatives (RFPN), security algorithms were developed. The aims were to estimate the prevalence of RFPN and of proven failures, and to identify factors associate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Poynard, Thierry, Munteanu, Mona, Deckmyn, Olivier, Ngo, Yen, Drane, Fabienne, Messous, Djamila, Castille, Jean Marie, Housset, Chantal, Ratziu, Vlad, Imbert-Bismut, Françoise
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2011
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3097002/
https://ncbi.nlm.nih.gov/pubmed/21492460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-11-39
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia